You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 125 No. 3, March 1990 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE ANNUAL MEETING OF THE SOCIETY OF SURGICAL ONCOLOGY, SAN FRANCISCO, CALIF, MAY 21 TO MAY 24, 1989-PAR T II
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Isolated Limb Perfusion for Localized Melanoma of the Extremity

A Matched Comparison of Wide Local Excision With Isolated Limb Perfusion and Wide Local Excision Alone

Michael J. Edwards, MD; Seng-Jaw Soong, PhD; Arthur W. Boddie, MD; Charles M. Balch, MD; Charles M. McBride, MD

Arch Surg. 1990;125(3):317-321.


Abstract

• The therapeutic efficacy of isolated limb perfusion in patients with localized melanoma of the extremity remains controversial. We compared patients treated at the University of Texas M. D. Anderson Cancer Center, Houston, with wide local excision and isolated limb perfusion using either melphalan or imidazole carboxamide with a group matched for prognostic factors from the University of Alabama at Birmingham and the University of Sydney (Australia) who were treated with wide local excision alone. No significant difference in disease-free or overall survival rates was found between patients treated with wide local excision with adjuvant isolated limb perfusion or wide local excision alone. However, a subset of patients with thicker lesions (>2.0 mm) treated with wide local excision and isolated limb perfusion using melphalan had a significant improvement in both diseasefree and overall survival rates. These data suggest that isolated limb perfusion using melphalan may improve survival rates in selected patients with localized melanoma of the extremity who are at increased risk for local and regional micrometastases, and justifies the continued study of this treatment approach in prospective clinical trials.

(Arch Surg. 1990;125:317-321)



Author Affiliations

From the Department of General Surgery, Division of Surgery, University of Texas M. D. Anderson Cancer Center, Houston (Drs Edwards, Boddie, Balch, and McBride), and the Cancer Biostatistics Section, Laurleen B. Wallace Cancer Center, University of Alabama at Birmingham (Dr Soong). Dr Edwards is now with the University of Louisville (Ky) Medical School.


Footnotes

Accepted for publication December 2, 1989.

Read before the annual meeting of the Society of Surgical Oncology, San Francisco, Calif, May 23, 1989.

Reprint requests to the Department of Surgery, University of Louisville, 550 S Jackson St, Louisville, KY 40292 (Dr Edwards).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Venovenous perfusion-induced systemic hyperthermia: hemodynamics, blood flow, and thermal gradients
Vertrees et al.
Ann. Thorac. Surg. 2000;70:644-652.
ABSTRACT | FULL TEXT  

Long-term Morbidity After Regional Isolated Perfusion With Melphalan for Melanoma of the Limbs: The Influence of Acute Regional Toxic Reactions
Vrouenraets et al.
Arch Surg 1995;130:43-47.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.